Check out the companies making the biggest moves midday: KLA Corp. — The semiconductor equipment maker jumped 4%, nearing a 52-week high, after Jefferies raised its 12-month price target to $1,500 from $1,200, saying “AI continues to drive spend with [wafer fab equipment] accelerating into C26/C27,” and citing KLA’s “outsized exposure to the Leading Edge.” Immunome — The biotech company surged 20% after releasing positive Phase 3 trial results for varegacestat, a drug that aims to treat desmoid tumors. “These findings demonstrate the potential of varegacestat to offer best-in-class results in a convenient, once-daily, oral medicine that may help patients reclaim their lives,” CEO Clay Siegall said in a statement. Zillow Group — Shares dipped 8% following a report that showed Google was testing a new format in which listings would appear directly on search results. Abercrombie & Fitch — The retailer added 6%, building on 18% gain from last week. The stock appears to be a beneficiary of an underlying market rotation out of tech and into other parts of the market. Year to date, shares remain 20% lower. Tilray — The cannabis stock fell 3%, giving back some of on last week’s rally sparked by news that President Donald Trump would instruct federal agencies to give the drug a less-stringent Schedule III classification from its current Schedule I designation. Las Vegas S …
